HIIFS
MYOV

Harel Insurance Investments & Financial Services’s Myovant Sciences Ltd. MYOV Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,000
Closed -$275K – 895
2021
Q1 		$275K Buy
+4,000
New +$91.1K 0.01% 561

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Harel Insurance Investments & Financial Services's MYOV Position: Q2 2021 in Review

Harel Insurance Investments & Financial Services sold out of Myovant Sciences Ltd. (MYOV) in Q2 2021, closing a stake of 4,000 shares — an estimated $275K sold.

Harel Insurance Investments & Financial Services first reported a position in MYOV in Q1 2021 and held it in 1 quarter. The position peaked at $275K in Q1 2021. 108 funds tracked by Wall St. Rank hold MYOV as of Q2 2021.

  • Harel Insurance Investments & Financial Services reported no remaining Myovant Sciences Ltd. position as of Q2 2021 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 4,000 Myovant Sciences Ltd. shares in Q2 2021, an estimated $275K.
  • Harel Insurance Investments & Financial Services first reported a position in Myovant Sciences Ltd. in Q1 2021 and held it in 1 quarter.
  • Harel Insurance Investments & Financial Services's Myovant Sciences Ltd. position peaked at $275K in Q1 2021.
  • 108 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2021.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2021, filed 26 Jul 2021.